AMPHENOL CORP /DE/ financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q4 2025.

Symbol
APH on NYSE
Location
Wallingford, CT
Fiscal year end
31 December
Latest financial report
08 Apr 2026

Shareable Research Card

APH - AMPHENOL CORP /DE/ Financial Facts

APH - AMPHENOL CORP /DE/ has a source-backed company facts page for reviewing reported financial metrics, periods, and linked metric histories.

Start with the latest metric summary, then open metric histories or cross-company rankings to compare the same SEC-backed facts.

Context
Latest metrics period: Q4 2025
Latest reported value
Return On Invested Capital 31%

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open metric pages to inspect the reported history.

Quick Takeaways

  • APH - AMPHENOL CORP /DE/ financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q4 2025.
  • Headline metric: Return On Invested Capital 31%.

What Changed

  • Return On Invested Capital YoY change: <span class="text-green-600">+41%</span>.
  • Most recent SEC facts end date: 31 Jan 2026.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Source Evidence

Based on latest 10-Q/10-K

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open company facts to inspect the reported metric history.

See Original Filing

Latest SEC snapshot (2026-01-31) highlights Return On Invested Capital 30.6%, Return On Equity 36.9%, and Return On Assets 13.1%.

Compare This Company Through SEC-backed Metrics

Use these links to compare APH - AMPHENOL CORP /DE/ against other SEC filers on the same metric, then verify the company history from the paired facts page.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

87.9/100

Strong Confidence high

Return On Invested Capital

31%

Metric score 100.0/100

Return On Equity

37%

Metric score 100.0/100

Return On Assets

13%

Metric score 100.0/100

Financial Health

Current Ratio
2.98x
Quick Ratio
2.37x
Debt to Equity
1.19x

Strengths

Return On Invested Capital, Return On Equity, and Return On Assets

Watchpoints

No major risk flags from available metrics.

Key metrics snapshot

Profitability

Metric Latest value YoY change
Return On Invested Capital 31% +41%
Return On Equity 37% +38%
Return On Assets 13% +16%
Operating Margin 27% +23%

Financial Health

Metric Latest value YoY change
Current Ratio 2.98x +26%
Quick Ratio 2.37x +46%
Debt-to-equity 1.19x +64%

Growth

Metric Latest value YoY change
Revenues YoY 52%
NetIncomeLoss YoY 76%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 1,229,214,930 +1.5%
Common Stock, Shares, Outstanding 1,226,600,000 +1.4%
Common Stock, Value, Issued $1,200,000 0%
Weighted Average Number of Shares Outstanding, Basic 1,218,200,000 +1.2%
Weighted Average Number of Shares Outstanding, Diluted 1,277,500,000 +1.1%

Additional Metrics

Metric Latest value YoY change
Revenue from Contract with Customer, Excluding Assessed Tax $23,094,700,000 +52%
Cost of Revenue $14,577,000,000 +45%
Operating Income (Loss) $5,868,600,000 +86%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $5,600,700,000 +86%
Income Tax Expense (Benefit) $1,295,400,000 +127%
Earnings Per Share, Basic 3.51 +75%
Earnings Per Share, Diluted 3.34 +74%
Cash and Cash Equivalents, at Carrying Value $11,130,600,000 +236%
Cash, Cash Equivalents, and Short-term Investments $11,434,200,000 +243%
Accounts Receivable, after Allowance for Credit Loss, Current $4,717,100,000 +43%
Inventory, Net $3,424,900,000 +35%
Assets, Current $20,267,200,000 +109%
Property, Plant and Equipment, Net $2,305,600,000 +35%
Operating Lease, Right-of-Use Asset $559,000,000 +45%
Intangible Assets, Net (Excluding Goodwill) $2,241,400,000 +83%
Goodwill $10,575,400,000 +28%
Other Assets, Noncurrent $847,300,000 +46%
Assets $36,236,900,000 +69%
Accounts Payable, Current $2,661,900,000 +46%
Employee-related Liabilities, Current $767,700,000 +45%
Liabilities, Current $6,802,800,000 +67%
Long-term Debt and Lease Obligation $14,564,800,000 +125%
Deferred Income Tax Liabilities, Net $432,900,000 +15%
Operating Lease, Liability, Noncurrent $424,600,000 +49%
Other Liabilities, Noncurrent $788,500,000 +55%
Liabilities $22,727,200,000 +96%
Accumulated Other Comprehensive Income (Loss), Net of Tax $479,500,000 +33%
Retained Earnings (Accumulated Deficit) $9,854,300,000 +39%
Stockholders' Equity Attributable to Parent $13,413,100,000 +37%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $13,500,400,000 +37%
Liabilities and Equity $36,236,900,000 +69%
Common Stock, Shares Authorized 5,000,000,000 +150%
Common Stock, Shares, Issued 1,228,900,000 +1.3%
Common Stock, Par or Stated Value Per Share 0.001 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $11,130,600,000 +236%
Deferred Tax Assets, Valuation Allowance $87,600,000 +19%
Deferred Tax Assets, Gross $735,300,000 +51%
Operating Lease, Liability $565,700,000 +44%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $4,507,100,000 +101%
Lessee, Operating Lease, Liability, to be Paid $649,300,000 +45%
Property, Plant and Equipment, Gross $5,401,600,000 +29%
Operating Lease, Liability, Current $141,100,000 +30%
Lessee, Operating Lease, Liability, to be Paid, Year Two $128,500,000 +42%
Lessee, Operating Lease, Liability, to be Paid, Year One $161,400,000 +33%
Operating Lease, Weighted Average Discount Rate, Percent 0.045 +4.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $83,600,000 +53%
Lessee, Operating Lease, Liability, to be Paid, Year Three $98,900,000 +51%
Unrecognized Tax Benefits $279,600,000 +58%
Lessee, Operating Lease, Liability, to be Paid, Year Four $72,600,000 +52%
Amortization of Intangible Assets $192,000,000 +24%
Depreciation, Depletion and Amortization $922,400,000 +61%
Deferred Tax Assets, Net of Valuation Allowance $647,700,000 +56%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY